AxoGen (AXGN)
(Delayed Data from NSDQ)
$12.67 USD
-0.42 (-3.21%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.66 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, AxoGen, Inc. has a market cap of $596.17M, which represents its share price of $13.09 multiplied by its outstanding shares number of 45.54M. As a small-cap company, AXGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AXGN 12.67 -0.42(-3.21%)
Will AXGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXGN
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
Other News for AXGN
Axogen (AXGN) Considers Potential Sale Amid Acquisition Interest
Axogen gains on report of takeover interest
AxoGen exploring possible sale after approach, Street Insider says
Axogen (AXGN) Considers Potential Sale Amid Takeover Proposal
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference | AXGN Stock News